Biocept reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 519,140 shares of its common stock to 44 new employees, including an inducement stock option to purchase 150,000 shares of its common stock to philippe marchand, ph.d., its new chief operations officer. the inducement stock options have a grant date of march 31, 2022, and were
BIOC Ratings Summary
BIOC Quant Ranking